Grant: Research Tools and Instruments - Category 1 (<$150,000)
McGill University
$150,000.00
High field NMR spectrometer for chemical biology research
EF 2007-08
Résumé
Most pharmaceuticals are small organic compounds that exert their influence by specifically interacting with a biological macromolecule such as a protein or nucleic acid and altering its function. The diversity of prospective therapeutic agents is enormous; the number small molecules that can exist in theory vastly exceeds the number that can ever be synthesized and tested. Thus our ability to control living systems chemically is limited primarily by the difficulty of uncovering appropriate molecules within the immense universe of possibilities. The field of Chemical Biology seeks to meet this challenge by studying the rules that govern macromolecule/drug interactions and how these interactions lead ultimately to a physiological effect. Two critical steps in this process are the synthesis of novel compounds and detailed characterization of their interactions with biological targets. In order for these steps to be successful, researchers must be able to elucidate the structures of the molecules in question with atomic resolution.Nuclear Magnetic Resonance (NMR) spectroscopy is an extremely powerful technique for determining the three-dimensional structures of organic compounds, biological macromolecules, and their complexes. We are requesting NMR equipment that will increase the availability and versatility of this vital tool in our research. The new infrastructure will be used to develop new synthetic routes to biologically important classes of compounds, improve chemically-modified oligonucleotides with potential applications against cancer, inflammatory, and infectious diseases, refine inhibitors of a bacterial drug-resistance enzyme, generate natural products and natural product hybrids, and study the fundamental thermodynamic principles underlying protein/drug interactions.
Programme
Research Tools and Instruments - Category 1 (<$150,000)
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
360010-2008
Name nom
Mittermaier, Anthony
Department département
Chemistry
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2007
Competition year année de concours
2008
Award amount
150000
Program id
EQPEQ
Program name en
Research Tools and Instruments - Category 1 (<$150,000)
Program name fr
Outils et instruments de recherche - catégorie 1 (<150 000$)
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
24
Committee name en
Inorganic & Organic Chemistry
Committee name fr
Chimie inorg. et org.
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
3700
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic chemistry
Research subject fr
Chimie organique
Partie
1
Nb partie
1
Application title
High field NMR spectrometer for chemical biology research
Keyword
NA
Application summary
Most pharmaceuticals are small organic compounds that exert their influence by specifically interacting with a biological macromolecule such as a protein or nucleic acid and altering its function. The diversity of prospective therapeutic agents is enormous; the number small molecules that can exist in theory vastly exceeds the number that can ever be synthesized and tested. Thus our ability to control living systems chemically is limited primarily by the difficulty of uncovering appropriate molecules within the immense universe of possibilities. The field of Chemical Biology seeks to meet this challenge by studying the rules that govern macromolecule/drug interactions and how these interactions lead ultimately to a physiological effect. Two critical steps in this process are the synthesis of novel compounds and detailed characterization of their interactions with biological targets. In order for these steps to be successful, researchers must be able to elucidate the structures of the molecules in question with atomic resolution.Nuclear Magnetic Resonance (NMR) spectroscopy is an extremely powerful technique for determining the three-dimensional structures of organic compounds, biological macromolecules, and their complexes. We are requesting NMR equipment that will increase the availability and versatility of this vital tool in our research. The new infrastructure will be used to develop new synthetic routes to biologically important classes of compounds, improve chemically-modified oligonucleotides with potential applications against cancer, inflammatory, and infectious diseases, refine inhibitors of a bacterial drug-resistance enzyme, generate natural products and natural product hybrids, and study the fundamental thermodynamic principles underlying protein/drug interactions.